TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 66 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $18,515,000 | +10.3% | 390,294 | -14.8% | 1.14% | +28.1% |
| Q1 2015 | $16,788,000 | -17.9% | 458,202 | -11.1% | 0.89% | -15.6% |
| Q4 2014 | $20,456,000 | +106.0% | 515,159 | +3.5% | 1.06% | +109.1% |
| Q3 2014 | $9,932,000 | +531.8% | 497,858 | +327.1% | 0.51% | +593.2% |
| Q2 2014 | $1,572,000 | -52.6% | 116,556 | -61.7% | 0.07% | -49.7% |
| Q1 2014 | $3,317,000 | – | 304,682 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 664,000 | $2,543,000 | 0.82% |
| GREAT POINT PARTNERS LLC | 452,375 | $1,733,000 | 0.44% |
| Clearline Capital LP | 267,915 | $1,026,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,149,000,000 | 0.18% |
| Rock Springs Capital Management LP | 662,500 | $2,537,000 | 0.16% |
| Eventide Asset Management | 600,000 | $2,298,000 | 0.14% |
| Granahan Investment Management | 657,496 | $2,518,000 | 0.08% |
| Candriam S.C.A. | 374,000 | $1,432,000 | 0.03% |
| Tekla Capital Management LLC | 192,322 | $737,000 | 0.03% |
| DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.02% |